Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
Crossref DOI link: https://doi.org/10.1186/s12885-015-1759-y
Published Online: 2015-10-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Seung Tae
Ahn, Tae Jin
Lee, Eunjin
Do, In-Gu
Lee, Su Jin
Park, Se Hoon
Park, Joon Oh
Park, Young Suk
Lim, Ho Yeong
Kang, Won Ki
Kim, Suk Hyeong
Lee, Jeeyun
Kim, Hee Cheol
License valid from 2015-10-20